Marjan Geugien

1.1k total citations
13 papers, 605 citations indexed

About

Marjan Geugien is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Marjan Geugien has authored 13 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Marjan Geugien's work include Acute Myeloid Leukemia Research (8 papers), Epigenetics and DNA Methylation (6 papers) and Cell death mechanisms and regulation (3 papers). Marjan Geugien is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Epigenetics and DNA Methylation (6 papers) and Cell death mechanisms and regulation (3 papers). Marjan Geugien collaborates with scholars based in Netherlands, United States and Brazil. Marjan Geugien's co-authors include Edo Vellenga, Hein Schepers, W. Kruijer, Kim U. Birkenkamp, Bart J. L. Eggen, Jan Jacob Schuringa, Annet Z. Brouwers-Vos, Joost H.A. Martens, Cristina Albuquerque and Winfried Edelmann and has published in prestigious journals such as Nature Communications, Blood and Cell Reports.

In The Last Decade

Marjan Geugien

13 papers receiving 599 citations

Peers

Countries citing papers authored by Marjan Geugien

Since Specialization

Citations

This map shows the geographic impact of Marjan Geugien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjan Geugien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjan Geugien more than expected).

Fields of papers citing papers by Marjan Geugien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjan Geugien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjan Geugien. The network helps show where Marjan Geugien may publish in the future.

Co-authorship network of co-authors of Marjan Geugien

This figure shows the co-authorship network connecting the top 25 collaborators of Marjan Geugien. A scholar is included among the top collaborators of Marjan Geugien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjan Geugien. Marjan Geugien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia 2023 ·Blood Advances ·Alan Cunningham, (unknown), Marjan Geugien, Diego A. Pereira‐Martins, Albertus T.J. Wierenga, (unknown), (unknown), Gerwin Huls, Jan Jacob Schuringa	16
2	The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia 2022 ·Nature Communications ·(unknown), Silvia Marín, Diego A. Pereira‐Martins, R. Cortès, Alan Cunningham, Maurien Pruis, Bauke de Boer, Fiona A.J. van den Heuvel, Marjan Geugien, Albertus T.J. Wierenga, Annet Z. Brouwers-Vos, Eduardo Magalhães Rego, Gerwin Huls, Marta Cascante, Jan Jacob Schuringa	36
3	Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability 2022 ·Nature Communications ·(unknown), Silvia Marín, Diego A. Pereira‐Martins, Marjan Geugien, Alan Cunningham, Maurien Pruis, Isabel Weinhäuser, Albert Gerding, Barbara M. Bakker, Albertus T.J. Wierenga, Eduardo Magalhães Rego, Gerwin Huls, Marta Cascante, Jan Jacob Schuringa	34
4	Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells 2019 ·Experimental Hematology ·(unknown), Marjan Geugien, (unknown), Annet Z. Brouwers-Vos, Rudolf S.N. Fehrmann, Tihomira I. Todorova, Ulrich Steidl, Edo Vellenga, Hein Schepers	4
5	CD34⁺ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness genes and can be targeted by the BCL2 inhibitor venetoclax 2019 ·Haematologica ·(unknown), (unknown), Hendrik Folkerts, Marjan Geugien, (unknown), Arthur Flohr Svendsen, Guoqiang Yi, Joost H.A. Martens, Edo Vellenga	8
6	CITED2 affects leukemic cell survival by interfering with p53 activation 2017 ·Cell Death and Disease ·(unknown), (unknown), Marjan Geugien, Edo Vellenga, Hein Schepers	15
7	CITED2 Affects Leukemic Cell Survival By Interfering with p53 Activation 2016 ·Blood ·(unknown), (unknown), Marjan Geugien, Joost H.A. Martens, Edo Vellenga, Hein Schepers	5
8	Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis 2015 ·Cell Reports ·Vincent van den Boom, (unknown), Marjan Geugien, Aida Rodríguez López, Ana M. Sotoca, Jennifer Jaques, Annet Z. Brouwers-Vos, Fabrizia Fusetti, Richard W.J. Groen, Huipin Yuan, Anton C. Martens, Hendrik G. Stunnenberg, Edo Vellenga, Joost H.A. Martens, Jan Jacob Schuringa	108
9	HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun 2005 ·Experimental Hematology ·Hein Schepers, Marjan Geugien, Marco van der Toorn, Anton L. Bryantsev, Harm H. Kampinga, Bart J. L. Eggen, Edo Vellenga	37
10	Constitutive cytoplasmic localization of p21Waf1/Cip1 affects the apoptotic process in monocytic leukaemia 2003 ·Leukemia ·Hein Schepers, Marjan Geugien, Bart J. L. Eggen, Edo Vellenga	38
11	Constitutive NF-κB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway 2003 ·Leukemia ·Kim U. Birkenkamp, Marjan Geugien, Hein Schepers, (unknown), (unknown), Edo Vellenga	110
12	Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts 2001 ·Leukemia ·(unknown), Marjan Geugien, (unknown), W. Kruijer, Edo Vellenga	117
13	SomaticApc mutations are selected upon their capacity to inactivate the ?-catenin downregulating activity 2000 ·Genes Chromosomes and Cancer ·Ron Smits, Nandy Hofland, Winfried Edelmann, Marjan Geugien, Shantie Jagmohan–Changur, Cristina Albuquerque, Cor Breukel, Raju Kucherlapati, Menno F. Kielman, Riccardo Fodde	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact